 | • レポートコード：GIR-23F3767 • 出版社/出版日：GlobalInfoResearch / 2023年2月 • レポート形態：英文、PDF、123ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「Global Cancer Drugs Market」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 グローバルインフォリサーチ社（香港）の最新の調査によると、世界の抗がん剤の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 抗がん剤市場はタイプ（種類）とアプリケーション（用途）によって区分されます。2017年～2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 タイプ別セグメントは次を対象にします。 ・化学療法、標的療法、免疫療法、ホルモン療法（生物療法）、その他 アプリケーション別セグメントは次のように区分されます。 ・血液がん、乳がん、消化器がん、前立腺がん、呼吸器・肺がん、その他がん 世界の抗がん剤市場の主要なマーケットプレーヤーは以下のとおりです。 ・Roche、Novartis、Celgene、Bristol-Myers Squibb、Amgen、Johnson & Johnson、Pfizer、Takeda、Eli Lilly、AstraZeneca、Astellas、Merck & Co.、Sanofi、Bayer、Biogen Idec、Eisai、Teva、Otsuka、Merck KGaA、Ipsen、AbbVie、Gilead Sciences 地域別セグメントは次の地域・国を対象にします。 ・北米市場（米国、カナダ、メキシコ） ・ヨーロッパ市場（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋市場（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南米市場（ブラジル、アルゼンチン、コロンビア） ・中東・アフリカ市場（サウジアラビア、UAE、エジプト、南アフリカ） ***** 目次(一部) ***** ・市場概要 - 抗がん剤の概要 - タイプ別分析（2017年vs2021年vs2028年）：化学療法、標的療法、免疫療法、ホルモン療法（生物療法）、その他 - アプリケーション別分析（2017年vs2021年vs2028年）：血液がん、乳がん、消化器がん、前立腺がん、呼吸器・肺がん、その他がん - 世界の抗がん剤市場規模・予測 - 世界の抗がん剤生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Roche、Novartis、Celgene、Bristol-Myers Squibb、Amgen、Johnson & Johnson、Pfizer、Takeda、Eli Lilly、AstraZeneca、Astellas、Merck & Co.、Sanofi、Bayer、Biogen Idec、Eisai、Teva、Otsuka、Merck KGaA、Ipsen、AbbVie、Gilead Sciences ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・タイプ別分析2017年-2028年：化学療法、標的療法、免疫療法、ホルモン療法（生物療法）、その他 ・アプリケーション別分析2017年-2028年：血液がん、乳がん、消化器がん、前立腺がん、呼吸器・肺がん、その他がん ・抗がん剤の北米市場分析 - 抗がん剤の北米市場：タイプ別市場規模2017年-2028年 - 抗がん剤の北米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・抗がん剤のヨーロッパ市場分析 - ：抗がん剤のヨーロッパ市場：タイプ別市場規模2017年-2028年 - ：抗がん剤のヨーロッパ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・抗がん剤のアジア太平洋市場分析 - 抗がん剤のアジア太平洋市場：タイプ別市場規模2017年-2028年 - 抗がん剤のアジア太平洋市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・抗がん剤の南米市場分析 - 抗がん剤の南米市場：タイプ別市場規模2017年-2028年 - 抗がん剤の南米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・抗がん剤の中東・アフリカ市場分析 - 抗がん剤の中東・アフリカ市場：タイプ別市場規模2017年-2028年 - 抗がん剤の中東・アフリカ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Cancer Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Cancer Drugs market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Blood Cancer accounting for % of the Cancer Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Chemotherapy segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Cancer Drugs include Roche, Novartis, Celgene, Bristol-Myers Squibb, and Amgen, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Cancer Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Chemotherapy
Targeted Therapy
Immunotherapy
Hormonal Therapy (Biologic Therapy)
Others
Market segment by Application can be divided into
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory/Lung Cancer
Other Cancers
The key market players for global Cancer Drugs market are listed below:
Roche
Novartis
Celgene
Bristol-Myers Squibb
Amgen
Johnson & Johnson
Pfizer
Takeda
Eli Lilly
AstraZeneca
Astellas
Merck & Co.
Sanofi
Bayer
Biogen Idec
Eisai
Teva
Otsuka
Merck KGaA
Ipsen
AbbVie
Gilead Sciences
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Cancer Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Cancer Drugs, with price, sales, revenue and global market share of Cancer Drugs from 2019 to 2022.
Chapter 3, the Cancer Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cancer Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Cancer Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Cancer Drugs.
Chapter 13, 14, and 15, to describe Cancer Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Cancer Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Cancer Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Chemotherapy
1.2.3 Targeted Therapy
1.2.4 Immunotherapy
1.2.5 Hormonal Therapy (Biologic Therapy)
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Cancer Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Blood Cancer
1.3.3 Breast Cancer
1.3.4 Gastrointestinal Cancer
1.3.5 Prostate Cancer
1.3.6 Respiratory/Lung Cancer
1.3.7 Other Cancers
1.4 Global Cancer Drugs Market Size & Forecast
1.4.1 Global Cancer Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Cancer Drugs Sales in Volume (2017-2028)
1.4.3 Global Cancer Drugs Price (2017-2028)
1.5 Global Cancer Drugs Production Capacity Analysis
1.5.1 Global Cancer Drugs Total Production Capacity (2017-2028)
1.5.2 Global Cancer Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Cancer Drugs Market Drivers
1.6.2 Cancer Drugs Market Restraints
1.6.3 Cancer Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Cancer Drugs Product and Services
2.1.4 Roche Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Cancer Drugs Product and Services
2.2.4 Novartis Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Celgene
2.3.1 Celgene Details
2.3.2 Celgene Major Business
2.3.3 Celgene Cancer Drugs Product and Services
2.3.4 Celgene Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Bristol-Myers Squibb
2.4.1 Bristol-Myers Squibb Details
2.4.2 Bristol-Myers Squibb Major Business
2.4.3 Bristol-Myers Squibb Cancer Drugs Product and Services
2.4.4 Bristol-Myers Squibb Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Amgen
2.5.1 Amgen Details
2.5.2 Amgen Major Business
2.5.3 Amgen Cancer Drugs Product and Services
2.5.4 Amgen Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Johnson & Johnson
2.6.1 Johnson & Johnson Details
2.6.2 Johnson & Johnson Major Business
2.6.3 Johnson & Johnson Cancer Drugs Product and Services
2.6.4 Johnson & Johnson Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Pfizer
2.7.1 Pfizer Details
2.7.2 Pfizer Major Business
2.7.3 Pfizer Cancer Drugs Product and Services
2.7.4 Pfizer Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Takeda
2.8.1 Takeda Details
2.8.2 Takeda Major Business
2.8.3 Takeda Cancer Drugs Product and Services
2.8.4 Takeda Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Eli Lilly
2.9.1 Eli Lilly Details
2.9.2 Eli Lilly Major Business
2.9.3 Eli Lilly Cancer Drugs Product and Services
2.9.4 Eli Lilly Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 AstraZeneca
2.10.1 AstraZeneca Details
2.10.2 AstraZeneca Major Business
2.10.3 AstraZeneca Cancer Drugs Product and Services
2.10.4 AstraZeneca Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Astellas
2.11.1 Astellas Details
2.11.2 Astellas Major Business
2.11.3 Astellas Cancer Drugs Product and Services
2.11.4 Astellas Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Merck & Co.
2.12.1 Merck & Co. Details
2.12.2 Merck & Co. Major Business
2.12.3 Merck & Co. Cancer Drugs Product and Services
2.12.4 Merck & Co. Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Sanofi
2.13.1 Sanofi Details
2.13.2 Sanofi Major Business
2.13.3 Sanofi Cancer Drugs Product and Services
2.13.4 Sanofi Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Bayer
2.14.1 Bayer Details
2.14.2 Bayer Major Business
2.14.3 Bayer Cancer Drugs Product and Services
2.14.4 Bayer Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Biogen Idec
2.15.1 Biogen Idec Details
2.15.2 Biogen Idec Major Business
2.15.3 Biogen Idec Cancer Drugs Product and Services
2.15.4 Biogen Idec Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Eisai
2.16.1 Eisai Details
2.16.2 Eisai Major Business
2.16.3 Eisai Cancer Drugs Product and Services
2.16.4 Eisai Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17 Teva
2.17.1 Teva Details
2.17.2 Teva Major Business
2.17.3 Teva Cancer Drugs Product and Services
2.17.4 Teva Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18 Otsuka
2.18.1 Otsuka Details
2.18.2 Otsuka Major Business
2.18.3 Otsuka Cancer Drugs Product and Services
2.18.4 Otsuka Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19 Merck KGaA
2.19.1 Merck KGaA Details
2.19.2 Merck KGaA Major Business
2.19.3 Merck KGaA Cancer Drugs Product and Services
2.19.4 Merck KGaA Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.20 Ipsen
2.20.1 Ipsen Details
2.20.2 Ipsen Major Business
2.20.3 Ipsen Cancer Drugs Product and Services
2.20.4 Ipsen Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.21 AbbVie
2.21.1 AbbVie Details
2.21.2 AbbVie Major Business
2.21.3 AbbVie Cancer Drugs Product and Services
2.21.4 AbbVie Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.22 Gilead Sciences
2.22.1 Gilead Sciences Details
2.22.2 Gilead Sciences Major Business
2.22.3 Gilead Sciences Cancer Drugs Product and Services
2.22.4 Gilead Sciences Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Cancer Drugs Breakdown Data by Manufacturer
3.1 Global Cancer Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Cancer Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Cancer Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Cancer Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Cancer Drugs Manufacturer Market Share in 2021
3.5 Global Cancer Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Cancer Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Cancer Drugs Market Size by Region
4.1.1 Global Cancer Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Cancer Drugs Revenue by Region (2017-2028)
4.2 North America Cancer Drugs Revenue (2017-2028)
4.3 Europe Cancer Drugs Revenue (2017-2028)
4.4 Asia-Pacific Cancer Drugs Revenue (2017-2028)
4.5 South America Cancer Drugs Revenue (2017-2028)
4.6 Middle East and Africa Cancer Drugs Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Cancer Drugs Sales in Volume by Type (2017-2028)
5.2 Global Cancer Drugs Revenue by Type (2017-2028)
5.3 Global Cancer Drugs Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Cancer Drugs Sales in Volume by Application (2017-2028)
6.2 Global Cancer Drugs Revenue by Application (2017-2028)
6.3 Global Cancer Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Cancer Drugs Sales by Type (2017-2028)
7.2 North America Cancer Drugs Sales by Application (2017-2028)
7.3 North America Cancer Drugs Market Size by Country
7.3.1 North America Cancer Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Cancer Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Cancer Drugs Sales by Type (2017-2028)
8.2 Europe Cancer Drugs Sales by Application (2017-2028)
8.3 Europe Cancer Drugs Market Size by Country
8.3.1 Europe Cancer Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Cancer Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Cancer Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Cancer Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Cancer Drugs Market Size by Region
9.3.1 Asia-Pacific Cancer Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Cancer Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Cancer Drugs Sales by Type (2017-2028)
10.2 South America Cancer Drugs Sales by Application (2017-2028)
10.3 South America Cancer Drugs Market Size by Country
10.3.1 South America Cancer Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Cancer Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Cancer Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Cancer Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Cancer Drugs Market Size by Country
11.3.1 Middle East & Africa Cancer Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Cancer Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Cancer Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Cancer Drugs
12.3 Cancer Drugs Production Process
12.4 Cancer Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Cancer Drugs Typical Distributors
13.3 Cancer Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
Table 1. Global Cancer Drugs Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Cancer Drugs Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Roche Basic Information, Manufacturing Base and Competitors
Table 4. Roche Major Business
Table 5. Roche Cancer Drugs Product and Services
Table 6. Roche Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Novartis Basic Information, Manufacturing Base and Competitors
Table 8. Novartis Major Business
Table 9. Novartis Cancer Drugs Product and Services
Table 10. Novartis Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Celgene Basic Information, Manufacturing Base and Competitors
Table 12. Celgene Major Business
Table 13. Celgene Cancer Drugs Product and Services
Table 14. Celgene Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 16. Bristol-Myers Squibb Major Business
Table 17. Bristol-Myers Squibb Cancer Drugs Product and Services
Table 18. Bristol-Myers Squibb Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Amgen Basic Information, Manufacturing Base and Competitors
Table 20. Amgen Major Business
Table 21. Amgen Cancer Drugs Product and Services
Table 22. Amgen Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 24. Johnson & Johnson Major Business
Table 25. Johnson & Johnson Cancer Drugs Product and Services
Table 26. Johnson & Johnson Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Pfizer Basic Information, Manufacturing Base and Competitors
Table 28. Pfizer Major Business
Table 29. Pfizer Cancer Drugs Product and Services
Table 30. Pfizer Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Takeda Basic Information, Manufacturing Base and Competitors
Table 32. Takeda Major Business
Table 33. Takeda Cancer Drugs Product and Services
Table 34. Takeda Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 36. Eli Lilly Major Business
Table 37. Eli Lilly Cancer Drugs Product and Services
Table 38. Eli Lilly Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 40. AstraZeneca Major Business
Table 41. AstraZeneca Cancer Drugs Product and Services
Table 42. AstraZeneca Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Astellas Basic Information, Manufacturing Base and Competitors
Table 44. Astellas Major Business
Table 45. Astellas Cancer Drugs Product and Services
Table 46. Astellas Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Merck & Co. Basic Information, Manufacturing Base and Competitors
Table 48. Merck & Co. Major Business
Table 49. Merck & Co. Cancer Drugs Product and Services
Table 50. Merck & Co. Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Sanofi Basic Information, Manufacturing Base and Competitors
Table 52. Sanofi Major Business
Table 53. Sanofi Cancer Drugs Product and Services
Table 54. Sanofi Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Bayer Basic Information, Manufacturing Base and Competitors
Table 56. Bayer Major Business
Table 57. Bayer Cancer Drugs Product and Services
Table 58. Bayer Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Biogen Idec Basic Information, Manufacturing Base and Competitors
Table 60. Biogen Idec Major Business
Table 61. Biogen Idec Cancer Drugs Product and Services
Table 62. Biogen Idec Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Eisai Basic Information, Manufacturing Base and Competitors
Table 64. Eisai Major Business
Table 65. Eisai Cancer Drugs Product and Services
Table 66. Eisai Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 67. Teva Basic Information, Manufacturing Base and Competitors
Table 68. Teva Major Business
Table 69. Teva Cancer Drugs Product and Services
Table 70. Teva Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 71. Otsuka Basic Information, Manufacturing Base and Competitors
Table 72. Otsuka Major Business
Table 73. Otsuka Cancer Drugs Product and Services
Table 74. Otsuka Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 75. Merck KGaA Basic Information, Manufacturing Base and Competitors
Table 76. Merck KGaA Major Business
Table 77. Merck KGaA Cancer Drugs Product and Services
Table 78. Merck KGaA Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 79. Ipsen Basic Information, Manufacturing Base and Competitors
Table 80. Ipsen Major Business
Table 81. Ipsen Cancer Drugs Product and Services
Table 82. Ipsen Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 83. AbbVie Basic Information, Manufacturing Base and Competitors
Table 84. AbbVie Major Business
Table 85. AbbVie Cancer Drugs Product and Services
Table 86. AbbVie Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 87. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 88. Gilead Sciences Major Business
Table 89. Gilead Sciences Cancer Drugs Product and Services
Table 90. Gilead Sciences Cancer Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 91. Global Cancer Drugs Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K MT)
Table 92. Global Cancer Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 93. Market Position of Manufacturers in Cancer Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 94. Global Cancer Drugs Production Capacity by Company, (K MT): 2020 VS 2021
Table 95. Head Office and Cancer Drugs Production Site of Key Manufacturer
Table 96. Cancer Drugs New Entrant and Capacity Expansion Plans
Table 97. Cancer Drugs Mergers & Acquisitions in the Past Five Years
Table 98. Global Cancer Drugs Sales by Region (2017-2022) & (K MT)
Table 99. Global Cancer Drugs Sales by Region (2023-2028) & (K MT)
Table 100. Global Cancer Drugs Revenue by Region (2017-2022) & (USD Million)
Table 101. Global Cancer Drugs Revenue by Region (2023-2028) & (USD Million)
Table 102. Global Cancer Drugs Sales by Type (2017-2022) & (K MT)
Table 103. Global Cancer Drugs Sales by Type (2023-2028) & (K MT)
Table 104. Global Cancer Drugs Revenue by Type (2017-2022) & (USD Million)
Table 105. Global Cancer Drugs Revenue by Type (2023-2028) & (USD Million)
Table 106. Global Cancer Drugs Price by Type (2017-2022) & (USD/MT)
Table 107. Global Cancer Drugs Price by Type (2023-2028) & (USD/MT)
Table 108. Global Cancer Drugs Sales by Application (2017-2022) & (K MT)
Table 109. Global Cancer Drugs Sales by Application (2023-2028) & (K MT)
Table 110. Global Cancer Drugs Revenue by Application (2017-2022) & (USD Million)
Table 111. Global Cancer Drugs Revenue by Application (2023-2028) & (USD Million)
Table 112. Global Cancer Drugs Price by Application (2017-2022) & (USD/MT)
Table 113. Global Cancer Drugs Price by Application (2023-2028) & (USD/MT)
Table 114. North America Cancer Drugs Sales by Country (2017-2022) & (K MT)
Table 115. North America Cancer Drugs Sales by Country (2023-2028) & (K MT)
Table 116. North America Cancer Drugs Revenue by Country (2017-2022) & (USD Million)
Table 117. North America Cancer Drugs Revenue by Country (2023-2028) & (USD Million)
Table 118. North America Cancer Drugs Sales by Type (2017-2022) & (K MT)
Table 119. North America Cancer Drugs Sales by Type (2023-2028) & (K MT)
Table 120. North America Cancer Drugs Sales by Application (2017-2022) & (K MT)
Table 121. North America Cancer Drugs Sales by Application (2023-2028) & (K MT)
Table 122. Europe Cancer Drugs Sales by Country (2017-2022) & (K MT)
Table 123. Europe Cancer Drugs Sales by Country (2023-2028) & (K MT)
Table 124. Europe Cancer Drugs Revenue by Country (2017-2022) & (USD Million)
Table 125. Europe Cancer Drugs Revenue by Country (2023-2028) & (USD Million)
Table 126. Europe Cancer Drugs Sales by Type (2017-2022) & (K MT)
Table 127. Europe Cancer Drugs Sales by Type (2023-2028) & (K MT)
Table 128. Europe Cancer Drugs Sales by Application (2017-2022) & (K MT)
Table 129. Europe Cancer Drugs Sales by Application (2023-2028) & (K MT)
Table 130. Asia-Pacific Cancer Drugs Sales by Region (2017-2022) & (K MT)
Table 131. Asia-Pacific Cancer Drugs Sales by Region (2023-2028) & (K MT)
Table 132. Asia-Pacific Cancer Drugs Revenue by Region (2017-2022) & (USD Million)
Table 133. Asia-Pacific Cancer Drugs Revenue by Region (2023-2028) & (USD Million)
Table 134. Asia-Pacific Cancer Drugs Sales by Type (2017-2022) & (K MT)
Table 135. Asia-Pacific Cancer Drugs Sales by Type (2023-2028) & (K MT)
Table 136. Asia-Pacific Cancer Drugs Sales by Application (2017-2022) & (K MT)
Table 137. Asia-Pacific Cancer Drugs Sales by Application (2023-2028) & (K MT)
Table 138. South America Cancer Drugs Sales by Country (2017-2022) & (K MT)
Table 139. South America Cancer Drugs Sales by Country (2023-2028) & (K MT)
Table 140. South America Cancer Drugs Revenue by Country (2017-2022) & (USD Million)
Table 141. South America Cancer Drugs Revenue by Country (2023-2028) & (USD Million)
Table 142. South America Cancer Drugs Sales by Type (2017-2022) & (K MT)
Table 143. South America Cancer Drugs Sales by Type (2023-2028) & (K MT)
Table 144. South America Cancer Drugs Sales by Application (2017-2022) & (K MT)
Table 145. South America Cancer Drugs Sales by Application (2023-2028) & (K MT)
Table 146. Middle East & Africa Cancer Drugs Sales by Region (2017-2022) & (K MT)
Table 147. Middle East & Africa Cancer Drugs Sales by Region (2023-2028) & (K MT)
Table 148. Middle East & Africa Cancer Drugs Revenue by Region (2017-2022) & (USD Million)
Table 149. Middle East & Africa Cancer Drugs Revenue by Region (2023-2028) & (USD Million)
Table 150. Middle East & Africa Cancer Drugs Sales by Type (2017-2022) & (K MT)
Table 151. Middle East & Africa Cancer Drugs Sales by Type (2023-2028) & (K MT)
Table 152. Middle East & Africa Cancer Drugs Sales by Application (2017-2022) & (K MT)
Table 153. Middle East & Africa Cancer Drugs Sales by Application (2023-2028) & (K MT)
Table 154. Cancer Drugs Raw Material
Table 155. Key Manufacturers of Cancer Drugs Raw Materials
Table 156. Direct Channel Pros & Cons
Table 157. Indirect Channel Pros & Cons
Table 158. Cancer Drugs Typical Distributors
Table 159. Cancer Drugs Typical Customers
List of Figures
Figure 1. Cancer Drugs Picture
Figure 2. Global Cancer Drugs Revenue Market Share by Type in 2021
Figure 3. Chemotherapy
Figure 4. Targeted Therapy
Figure 5. Immunotherapy
Figure 6. Hormonal Therapy (Biologic Therapy)
Figure 7. Others
Figure 8. Global Cancer Drugs Revenue Market Share by Application in 2021
Figure 9. Blood Cancer
Figure 10. Breast Cancer
Figure 11. Gastrointestinal Cancer
Figure 12. Prostate Cancer
Figure 13. Respiratory/Lung Cancer
Figure 14. Other Cancers
Figure 15. Global Cancer Drugs Revenue, (USD Million) & (K MT): 2017 & 2021 & 2028
Figure 16. Global Cancer Drugs Revenue and Forecast (2017-2028) & (USD Million)
Figure 17. Global Cancer Drugs Sales (2017-2028) & (K MT)
Figure 18. Global Cancer Drugs Price (2017-2028) & (USD/MT)
Figure 19. Global Cancer Drugs Production Capacity (2017-2028) & (K MT)
Figure 20. Global Cancer Drugs Production Capacity by Geographic Region: 2022 VS 2028
Figure 21. Cancer Drugs Market Drivers
Figure 22. Cancer Drugs Market Restraints
Figure 23. Cancer Drugs Market Trends
Figure 24. Global Cancer Drugs Sales Market Share by Manufacturer in 2021
Figure 25. Global Cancer Drugs Revenue Market Share by Manufacturer in 2021
Figure 26. Cancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 27. Top 3 Cancer Drugs Manufacturer (Revenue) Market Share in 2021
Figure 28. Top 6 Cancer Drugs Manufacturer (Revenue) Market Share in 2021
Figure 29. Global Cancer Drugs Sales Market Share by Region (2017-2028)
Figure 30. Global Cancer Drugs Revenue Market Share by Region (2017-2028)
Figure 31. North America Cancer Drugs Revenue (2017-2028) & (USD Million)
Figure 32. Europe Cancer Drugs Revenue (2017-2028) & (USD Million)
Figure 33. Asia-Pacific Cancer Drugs Revenue (2017-2028) & (USD Million)
Figure 34. South America Cancer Drugs Revenue (2017-2028) & (USD Million)
Figure 35. Middle East & Africa Cancer Drugs Revenue (2017-2028) & (USD Million)
Figure 36. Global Cancer Drugs Sales Market Share by Type (2017-2028)
Figure 37. Global Cancer Drugs Revenue Market Share by Type (2017-2028)
Figure 38. Global Cancer Drugs Price by Type (2017-2028) & (USD/MT)
Figure 39. Global Cancer Drugs Sales Market Share by Application (2017-2028)
Figure 40. Global Cancer Drugs Revenue Market Share by Application (2017-2028)
Figure 41. Global Cancer Drugs Price by Application (2017-2028) & (USD/MT)
Figure 42. North America Cancer Drugs Sales Market Share by Type (2017-2028)
Figure 43. North America Cancer Drugs Sales Market Share by Application (2017-2028)
Figure 44. North America Cancer Drugs Sales Market Share by Country (2017-2028)
Figure 45. North America Cancer Drugs Revenue Market Share by Country (2017-2028)
Figure 46. United States Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Canada Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Mexico Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Europe Cancer Drugs Sales Market Share by Type (2017-2028)
Figure 50. Europe Cancer Drugs Sales Market Share by Application (2017-2028)
Figure 51. Europe Cancer Drugs Sales Market Share by Country (2017-2028)
Figure 52. Europe Cancer Drugs Revenue Market Share by Country (2017-2028)
Figure 53. Germany Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. France Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. United Kingdom Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Russia Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Italy Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Asia-Pacific Cancer Drugs Sales Market Share by Region (2017-2028)
Figure 59. Asia-Pacific Cancer Drugs Sales Market Share by Application (2017-2028)
Figure 60. Asia-Pacific Cancer Drugs Sales Market Share by Region (2017-2028)
Figure 61. Asia-Pacific Cancer Drugs Revenue Market Share by Region (2017-2028)
Figure 62. China Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Japan Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Korea Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. India Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Southeast Asia Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Australia Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. South America Cancer Drugs Sales Market Share by Type (2017-2028)
Figure 69. South America Cancer Drugs Sales Market Share by Application (2017-2028)
Figure 70. South America Cancer Drugs Sales Market Share by Country (2017-2028)
Figure 71. South America Cancer Drugs Revenue Market Share by Country (2017-2028)
Figure 72. Brazil Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Argentina Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Middle East & Africa Cancer Drugs Sales Market Share by Type (2017-2028)
Figure 75. Middle East & Africa Cancer Drugs Sales Market Share by Application (2017-2028)
Figure 76. Middle East & Africa Cancer Drugs Sales Market Share by Region (2017-2028)
Figure 77. Middle East & Africa Cancer Drugs Revenue Market Share by Region (2017-2028)
Figure 78. Turkey Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Egypt Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Saudi Arabia Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. South Africa Cancer Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 82. Manufacturing Cost Structure Analysis of Cancer Drugs in 2021
Figure 83. Manufacturing Process Analysis of Cancer Drugs
Figure 84. Cancer Drugs Industrial Chain
Figure 85. Sales Channel: Direct Channel vs Indirect Channel
Figure 86. Methodology
Figure 87. Research Process and Data Source